Egger K

Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.

10 papers · 2 preprints · ORCID

ArticlePsilocybin

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [18F]FDG-PET study.

Egger K, Bozsak R, Aicher HD +9

Europe PMC2026

ArticlePsilocybin

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat.

Egger K, Meling D, Polat F +3

Europe PMC2025

PreprintPsilocybin

Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat

Egger K, Meling D, Polat F +3

Europe PMC2025

PreprintPsilocybin

Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study

Egger K, Bozsak R, Aicher H +8

Europe PMC2025

ArticleAyahuasca

Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects.

Äbelö A, Smallridge JW, von Rotz R +4

Europe PMC2025

ArticlePsilocybin

Molecular brain imaging of psychedelic action.

Cumming P, Egger K, Knudsen GM

Europe PMC2025

ArticleAyahuasca

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.

Egger K, Jareño Redondo J, Müller J +13

Europe PMC2025

ArticleAyahuasca

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

Egger K, Aicher HD, Cumming P +1

Europe PMC2024

ArticleDMT

Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.

Meling D, Egger K, Aicher HD +11

Europe PMC2024

ArticleAyahuasca

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

Egger K, Aicher HD, Cumming P +1

Europe PMC2024

ArticleDMT

A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Egger K, Gudmundsen F, Jessen NS +10

Europe PMC2023

ArticleAyahuasca

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca.

Berlowitz I, Egger K, Cumming P

Europe PMC2022

Egger K

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [<sup>18</sup>F]FDG-PET study.

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat.

Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of <i>N,N</i>-Dimethyltryptamine and Harmine in a Meditation Retreat

Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study

Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects.

Molecular brain imaging of psychedelic action.

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

A pilot study of cerebral metabolism and serotonin 5-HT<sub>2A</sub> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca.

Egger K

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [&lt;sup&gt;18&lt;/sup&gt;F]FDG-PET study.

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of &lt;i&gt;N,N&lt;/i&gt;-dimethyltryptamine and harmine in a meditation retreat.

Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of <i>N,N</i>-Dimethyltryptamine and Harmine in a Meditation Retreat

Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study

Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects.

Molecular brain imaging of psychedelic action.

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

A pilot study of cerebral metabolism and serotonin 5-HT<sub>2A</sub> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca.

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [<sup>18</sup>F]FDG-PET study.

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat.